fda compounding semaglutide enforcement november 2025 news 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA to Restrict Ingredients Used

And we have seen just as many lawsuits by pharma companies against compounding GLP-1s, with the FDA also releasing a warning letter last month

Individuals who lose weight rapidly often face loose skin issues, making it crucial to remove excess skin surgically for a sculpted, toned chest and a more youthful appearance

Kumbhani D et al

Background on GLP-1 Medications GLP-1 receptor agonists were originally developed in the early 1990s to manage diabetes, with the first medications reaching clinical use in 2005

If your last blood panel was more than six months ago or if youve never had a comprehensive metabolic workup getting current results before starting is the standard of care